Regeneron
LIBTAYO
Manufacturer:
Regeneron
Name:
LIBTAYO
HCPCS Code Descriptor:
Injection, cemiplimab-rwlc, 1 mg
Category:
J Code
HCPCS:
J9119
NDC(s):
61755-0008-01
Primary Type:
Oncology
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
LIBTAYO is an Oncology drug manufactured by Regeneron and administered via the Intravenous route of administration. The J Code: J9119 is aligned to the drug LIBTAYO.
Access Pricing and More By Registering
HCPCS Added Date:
10/1/19
HCPCS Effective Date:
10/1/19
HCPCS Short Description:
Inj., cemiplimab-rwlc, 1 mg
Billing and Coding Guide:
https://www.libtayohcp.com/sfsites/c/resource/Libtayo_Surround_Resources_Assets_Part_2/quick-reference-coding-guide.pdf
Patient Assistance:
https://www.libtayo.com/support